跳至主要内容
临床试验/CTRI/2022/04/041890
CTRI/2022/04/041890已完成不适用

A clinical study to evaluate the safety and efficacy of the baby care products on a healthy pediatric population of the age group 01-36 months.

Marico Limited1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2022年4月18日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
1
主要终点
1.To evaluate the safety and efficacy of test products on a pediatric population by one month home use test in comparison to the baseline.

研究概览

简要总结

Study will be conducted to assess the safety and efficacy of the test products. After consenting and qualifying the inclusion and exclusion criteria subjects will be enrolled into the study. For the selected subjects, the test products will be dispensed for the usage of 28 days. The assessment will be performed for week 1, 2 and 4.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
1.00 Month(s) 至 36.00 Month(s)(—)
性别
All

入选标准

  • Subjects in the age group 1-12 months, 12-24 months and 24-36 months in nearly equal ratio (both genders inclusive)
  • Subjects in general good health as determined from a recent medical history
  • Subject’s mother/authorized legal representative, preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up.
  • Subject’s mother/authorized legal representative, preferably mother willing to abide by and comply with the study protocol.
  • Subject’s mother/legal representative agreeing not to use any other product of the same nature and change any habit or other regular products during the study period.

排除标准

  • A known history or present condition or any other concern that may require medical attention
  • Subejcts deemed unfit to participate in the study based on the general health and hygiene.
  • Babies whose parents and/or authorized legal guardian are not willing to sign the informed consent.

结局指标

主要结局

1.To evaluate the safety and efficacy of test products on a pediatric population by one month home use test in comparison to the baseline.

时间窗: 4 weeeks

2. To evaluate the skin health and quality by dermatological assessment and instrumental evaluation in comparison to the baseline.

时间窗: 4 weeeks

次要结局

未报告次要终点

研究者

申办方类型
Other [FMCG(Fast moving Consumer Goods)]

研究点 (1)

Loading locations...

相似试验

尚未招募
不适用
Study to test the safety and effectiveness of test product to provide various skin benefits in participants over 56 days of test product usage
CTRI/2025/06/089217Antonio Puig S.A30
已完成
不适用
A Clinical Investigation Examining the Performance and Handling of New 2-piece Ostomy Products in 28 People With an Ileostomy.Ileostomy - Stoma
NCT02064231Coloplast A/S28
已完成
不适用
Safety and Effectiveness of an Auricular SprayExcessive Ear Wax
NCT06085443YSLab99
进行中(未招募)
1 期
Ensayo clínico para determinar la eficacia y seguridad de la terapia cuadruple con subcitrato de bismuto potasio, metronidazol y tetraciclina con omeprazole administrados durante 10 dias para la erradicación de Helicobacter pylori: en comparacion con omeprazole, amoxicilina y claritromicina administrados durante 7 dias.Efficacy and Safety of Quadruple Therapy by Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Given x 10 days With Omeprazole in Eradication of Helicobacter pylori: A Comparison to Omeprazole, Amoxicillin and Clarithromycin Given x 7 days.Tratamiento de infecciones causadas por Helicobacter pylori.Treatment of Helicobacter pylori infections.MedDRA version: 9.1Level: HLTClassification code 10019375Term: Helicobacter infections
EUCTR2007-006280-78-ESAxcan Pharma Inc.400
已完成
不适用
Evaluation of Cutaneous Acceptability and Perceived Effectiveness of a Nasal Spray (Health Care Products)Acceptance, SocialSensitivity, Contact
NCT05508230Herbarium Laboratorio Botanico Ltda45